NxThera Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 23

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $406M

  • Investors
  • 1

NxThera General Information

Description

Developer of a medical based thermal therapy device designed to treat prostate cancer and other endourologic conditions. The company's medical based thermal therapy converts a few drops of sterile water to stored thermal energy in the form of vapor, which is delivered to prostate tissue to treat benign prostatic hyperplasia (BPH), enabling patients suffering from urologic conditions, prostate cancer and kidney cancer to heal without any side effects.

Contact Information

Website
www.nxthera.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7351 Kirkwood Lane North
  • Suite 138
  • Maple Grove, MN 55369
  • United States
+1 (763)
Primary Industry
Therapeutic Devices
Corporate Office
  • 7351 Kirkwood Lane North
  • Suite 138
  • Maple Grove, MN 55369
  • United States
+1 (763)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NxThera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Mar-2018 $406M Completed Generating Revenue
5. Later Stage VC (Series C) 19-Jul-2017 Completed Generating Revenue
4. Later Stage VC (Series C) 03-Dec-2015 Completed Generating Revenue
3. Early Stage VC (Series B) 05-Oct-2011 Completed Startup
2. Early Stage VC (Series A1) 16-Nov-2009 $3M $6.25M Completed Startup
1. Early Stage VC (Series A) 23-Jun-2008 $3.25M $3.25M Completed Startup
To view NxThera’s complete valuation and funding history, request access »

NxThera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C1
Series C
Series B
Series A1 8,983,650 $0.001000 8% $0.33 $0.33 $0.33 4.94%
Series A 7,057,592 $0.001000 8% $0.47 $0.47 $0.47 3.88%
To view NxThera’s complete cap table history, request access »

NxThera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a medical based thermal therapy device designed to treat prostate cancer and other endourologic conditions.
Therapeutic Devices
Maple Grove, MN
23 As of 2015

Minneapolis, MN
 

Hadera, Israel
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NxThera Competitors (3)

One of NxThera’s 3 competitors is Urologix, a Formerly VC-backed company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Urologix Formerly VC-backed Minneapolis, MN
iTind Formerly VC-backed Hadera, Israel
Boston Scientific Corporation Marlborough, MA
You’re viewing 3 of 3 competitors. Get the full list »

NxThera Patents

NxThera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3565493-B1 Transperineal vapor ablation systems Active 06-Jan-2017
EP-3565493-A1 Transperineal vapor ablation systems and methods Active 06-Jan-2017
EP-3565493-A4 Transperineal vapor ablation systems and methods Active 06-Jan-2017
WO-2018129466-A1 Transperineal vapor ablation systems and methods Inactive 06-Jan-2017
US-12096967-B2 Vapor ablation systems and methods Active 21-Dec-2016 A61B18/04
To view NxThera’s complete patent history, request access »

NxThera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NxThera Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aberdare Ventures Venture Capital Minority
Alafi Capital Company Venture Capital Minority
Ally Bridge Group Growth/Expansion Minority
American Medical Systems Corporation Minority
Arboretum Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

NxThera FAQs

  • When was NxThera founded?

    NxThera was founded in 2008.

  • Where is NxThera headquartered?

    NxThera is headquartered in Maple Grove, MN.

  • What is the size of NxThera?

    NxThera has 23 total employees.

  • What industry is NxThera in?

    NxThera’s primary industry is Therapeutic Devices.

  • Is NxThera a private or public company?

    NxThera is a Private company.

  • What is the current valuation of NxThera?

    The current valuation of NxThera is .

  • What is NxThera’s current revenue?

    The current revenue for NxThera is .

  • How much funding has NxThera raised over time?

    NxThera has raised $98M.

  • Who are NxThera’s investors?

    Aberdare Ventures, Alafi Capital Company, Ally Bridge Group, American Medical Systems, and Arboretum Ventures are 5 of 10 investors who have invested in NxThera.

  • Who are NxThera’s competitors?

    Urologix, iTind, and Boston Scientific are competitors of NxThera.

  • When was NxThera acquired?

    NxThera was acquired on 21-Mar-2018.

  • Who acquired NxThera?

    NxThera was acquired by Boston Scientific Ventures.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process